23:06 , Mar 20, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Gram-negative bacterial infection...
08:00 , Dec 7, 2009 |  BioCentury  |  Strategy

Meeting the Biota Quota

Biota Holdings Ltd. 's acquisition of MaxThera Inc. and Prolysis Ltd. fills some holes in its pipeline, which should help it achieve its long-term goal of having two or three out-licensed, royalty-generating compounds on the...